PrasadALermanARihalCS. Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): A mimic of acute myocardial infarction. Am Heart J2008; 155: 408–417.
RedforsBShaoYOmerovicE. Stress-induced cardiomyopathy (Takotsubo)–broken heart and mind?Vasc Health Risk Manag2013; 9: 149–154.
6.
PaurHWrightPTSikkelMB. High levels of circulating epinephrine trigger apical cardiodepression in a β2-adrenergic receptor/Gi-dependent manner: A new model of Takotsubo cardiomyopathy. Circulation2012; 126: 697–706.
7.
ShaoYRedforsBScharin TängM. Novel rat model reveals important roles of β-adrenoreceptors in stress-induced cardiomyopathy. Int J Cardiol2013; 168: 1943–1950.
8.
RedforsBShaoYWikströmJ. Contrast echocardiography reveals apparently normal coronary perfusion in a rat model of stress-induced (Takotsubo) cardiomyopathy. Eur Heart J Cardiovasc Imaging2013, 9August; [Epub ahead of print].
9.
MiglioreFZorziAMarraMP. Myocardial edema underlies dynamic T-wave inversion (Wellens’ ECG pattern) in patients with reversible left ventricular dysfunction. Heart Rhythm2011; 8: 1629–1634.
10.
MadiasJE. Is the ST-segment elevation in Takotsubo syndrome partially (or even totally) due to dyskinesis?Am J Cardiol2013; 111: 778–779.
11.
ElesberALermanABybeeKA. Myocardial perfusion in apical ballooning syndrome correlate of myocardial injury. Am Heart J2006; 152: e9–e13.
12.
KurisuSInoueIKawagoeT. Myocardial perfusion and fatty acid metabolism in patients with Tako-Tsubo-like left ventricular dysfunction. J Am Coll Cardiol2003; 41: 743–748.
13.
BybeeKAMurphyJPrasadA. Acute impairment of regional myocardial glucose uptake in the apical ballooning (Takotsubo) syndrome. J Nucl Cardiol2006 ; 13: 244–250.
14.
AkashiYJTakanoMMiyakeF. Scintigraphic imaging in Takotsubo cardiomyopathy. Herz2010; 35: 231–238.
15.
De BruyneBBarbatoE. Quantitative assessment of the coronary microvasculature: New tools for the black box. Circulation2013 ; 127: 2378–2379.
16.
FearonWFLowAFYongAS. Prognostic value of the index of microcirculatory resistance measured after primary percutaneous coronary intervention. Circulation2013; 127: 2436–2441.
17.
MangiacapraFPeaceAJDi SerafinoL. Intracoronary enalaprilat to reduce MICROvascular damage during percutaneous coronary intervention (promicro) study. J Am Coll Cardiol2013; 61: 615–621.